Latigo Biotherapeutics, Inc.

LTGO chart

Latigo Biotherapeutics, Inc. news

• Latigo Biotherapeutics (LTGO) Short Interest & Short Float | Updated Nov 2026

  MarketBeat · Nov 10, 6:06 PM EST

• Latigo Biotherapeutics at guggenheim conference: pain push gains pace By Investing.com

  Investing.com India · Nov 10, 9:09 AM EST

• Latigo Biotherapeutics (NASDAQ:LTGO) Stock Rating Raised to Hold at Wall Street Zen

  MarketBeat · Nov 7, 8:55 AM EST

• Latigo Biotherapeutics’ Q3 Loss Per Share Beats Estimate by $0.12

  TOKENPOST · Nov 7, 5:18 AM EST

• Latigo Biotherapeutics (LTGO) Stock Price, News & Analysis

  Stock Titan · Nov 7, 3:00 AM EST

• An investor reports 3.19 million Latigo Biotherapeutics (LTGO) shares in an ownership amendment.

  Stock Titan · Nov 6, 5:18 PM EST

• Latigo Biotherapeutics (NASDAQ:LTGO) Posts Earnings Results

  MarketBeat · Nov 5, 10:28 PM EST

• Latigo Biotherapeutics (NASDAQ:LTGO) Stock Price Down 22.4% - What's Next?

  MarketBeat · Nov 5, 2:02 PM EST

• Latigo Biotherapeutics Q3 2026 Earnings Results and Report

  MarketBeat · Nov 5, 9:10 AM EST

• Latigo Biotherapeutics Appoints Todd Smith CEO to Lead Late-Stage Development of Non-Opioid Pain Therapies

  citybiz · Nov 5, 8:31 AM EST

• Latigo Biotherapeutics names Todd Smith as new CEO

  StreetInsider · Nov 5, 6:49 AM EST

• Latigo Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights

  Yahoo Finance · Nov 5, 6:47 AM EST

Latigo Biotherapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-05
• 8-K8-K2026-11-05
• 10-Q10-Q2026-09-03
• 8-K8-K2026-09-03
• 8-K8-K2026-08-10
• S-1S-12026-07-17

About Latigo Biotherapeutics, Inc.

Ticker

LTGO (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Thousand Oaks, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2056611

Frequently asked questions